Identification of women at high risk of developing endometrial cancer on tamoxifen

被引：0
作者：
Berlière, M
Radikov, G
Galant, C
Piette, P
Marbaix, E
Donnez, J
机构：
[1] Univ Catholique Louvain, Dept Gynaecol, B-1200 Brussels, Belgium
[2] Univ Catholique Louvain, Dept Pathol, B-1200 Brussels, Belgium
来源：
EUROPEAN JOURNAL OF CANCER | 2000年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S35 / S36
页数：2
相关论文
共 6 条
[1]   A realistic clinical perspective of tamoxifen and endometrial carcinogenesis [J].
Assikis, VJ ;
Neven, P ;
Jordan, VC ;
Vergote, I .
EUROPEAN JOURNAL OF CANCER, 1996, 32A (09) :1464-1476
[2]   Uterine side effects of tamoxifen:: A need for systematic pretreatment screening [J].
Berlière, M ;
Charles, A ;
Galant, C ;
Donnez, J .
OBSTETRICS AND GYNECOLOGY, 1998, 91 (01) :40-44
[3]  
Carmichael PL, 1996, CANCER RES, V56, P1475
[4]   Lack of evidence from HPLC 32P-post-labelling for tamoxifen-DNA adducts in the human endometrium [J].
Carmichael, PL ;
Sardar, S ;
Crooks, N ;
Neven, P ;
Van Hoof, I ;
Ugwumadu, A ;
Bourne, T ;
Tomas, E ;
Hellberg, P ;
Hewer, AJ ;
Phillips, DH .
CARCINOGENESIS, 1999, 20 (02) :339-342
[5]   ENDOMETRIAL LESIONS IN PATIENTS UNDERGOING TAMOXIFEN THERAPY [J].
DEMUYLDER, X ;
NEVEN, P ;
DESOMER, M ;
VANBELLE, Y ;
VANDERICK, G ;
DEMUYLDER, E .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1991, 36 (02) :127-130
[6]   ADJUVANT TAMOXIFEN THERAPY FOR EARLY-STAGE BREAST-CANCER AND 2ND PRIMARY MALIGNANCIES [J].
RUTQVIST, LE ;
JOHANSSON, H ;
SIGNOMKLAO, T ;
JOHANSSON, U ;
FORNANDER, T ;
WILKING, N .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (09) :645-651
1